查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1602750

動物生物技術市場：按產品、按應用分類 - 2025-2030 年全球預測

Animal Biotechnology Market by Product (Diagnostic Tests, Drugs, Reporductive & Genetic Produtcs), Application (Development of Animal Pharmaceuticals, Food Safety & Drug Development, Preventive Care for Animals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年動物生物技術市場的市場規模為286.4億美元，預計到2024年將達到310.4億美元，複合年成長率為8.46%，到2030年將達到505.9億美元。

動物生物技術包括將科學和工程原理應用於動物或其生物實體的物質加工或生產，以改善動物繁殖、健康、生產力和效率。該部門專注於基因工程產品，這些產品能夠承受環境壓力，生產更有營養的牛奶和肉類，並提供客製化的生物解決方案，以滿足全球食品需求、藥品和農業生產力，這些對於發展增強的動物至關重要。該領域的應用範圍包括基因工程、克隆和生物製藥生產。最終用途包括農業、製藥和旨在改善動物健康和生產效率的研究機構。

主要市場統計
基準年[2023] 286.4億美元
預測年份 [2024] 310.4億美元
預測年份 [2030] 505.9億美元
複合年成長率（%） 8.46%

市場成長受到全球人口成長、對糧食安全日益關注以及向永續農業流程轉變的影響。基因組學和 CRISPR/Cas9 等基因編輯技術等生物技術創新正在推動進步，並為作物和牲畜的穩健做出貢獻。然而，牲畜疾病管理、生物製藥生產和提高動物福利標準也存在潛在機會。投資研發的公司可以利用與學術和研究機構的夥伴關係來促進創新並擴大其產品線。市場面臨道德爭論、嚴格的法律規範和有限的消費者意識等挑戰，可能會阻礙快速採用。解決這些限制需要透明地溝通利益、風險和道德考慮因素，以及強力的監管策略以確保接受和合規。

具有技術創新潛力的領域包括次世代定序、基因編輯的進步以及精準畜牧業的綜合生物資訊學。此外，專注於全球協作和跨行業夥伴關係可以增強多元化和可擴展性。這個市場的本質是動態的，強調永續實踐和道德考量。尋求發展的公司必須保持敏捷，應對複雜的動物生物技術領域，同時促進創新和監管合規。透過解決道德和監管問題並培養消費者信任，公司可以抓住畜牧業和醫療解決方案領域對生物技術進步不斷成長的需求。

市場動態：揭示快速發展的動物生物技術市場的關鍵市場洞察

供需的動態交互作用正在改變動物生物技術市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 人們越來越關注克隆和基因改造動物
    • 越來越受歡迎和接受以及監管部門的核准
    • 動物用藥品開發及動物預防醫療
  • 市場限制因素
    • 與動物生物技術產品相關的高成本倫理問題
  • 市場機會
    • 肉品消費量增加，人均動物醫療費用增加
    • 農業基因改造牲畜的生產
  • 市場問題
    • 食品對人體的潛在健康影響

波特五力：駕馭動物生物技術市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解動物生物技術市場的外部影響

外部宏觀環境因素在塑造動物生物技術市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解動物生物技術市場的競爭格局

對動物生物技術市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：動物生物技術市場供應商的績效評估

FPNV 定位矩陣是評估動物生物技術市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：規劃動物生物技術市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對動物生物技術市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人們越來越關注克隆和基因改造動物
      • 越來越受歡迎和接受以及監管部門的核准
      • 動物用藥品開發和動物預防保健
    • 抑制因素
      • 與動物生物技術產品相關的高成本倫理問題
    • 機會
      • 動物肉類消費量增加，人均動物醫療費用上升
      • 農業基因改造牲畜的生產
    • 任務
      • 食品對人類健康的潛在影響
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章動物生物技術市場：依產品

  • 介紹
  • 診斷測試
  • 藥品
  • 生殖和遺傳產品
  • 疫苗

第7章動物生物技術市場：依應用分類

  • 介紹
  • 動物用藥品開發
  • 食品安全和藥物開發
  • 預防保健

第8章美洲動物生物技術市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太動物生物技術市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲動物生物技術市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Bayer AG
  • BioChek BV
  • Biogenesis Bago
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • Heska Corporation
  • Hester Biosciences Limited
  • IDEXX Laboratories, Inc.
  • Indian Immunologicals Ltd.
  • Intervet Inc.
  • Kareo, Inc.
  • Merck & Co., Inc.
  • Sanofi-Aventis Groupe SA
  • Santa Cruz BIoTechnology, Inc.
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-437517DB6EAD

The Animal Biotechnology Market was valued at USD 28.64 billion in 2023, expected to reach USD 31.04 billion in 2024, and is projected to grow at a CAGR of 8.46%, to USD 50.59 billion by 2030.

Animal biotechnology encompasses the application of scientific and engineering principles to the processing or production of materials by animals or their biological entities, aiming to improve animal breeding, health, productivity, and efficiencies. This field is essential for developing genetically enhanced animals that can withstand environmental stresses, produce more nutritionally enriched milk or meat, and provide biologically based solutions tailored to address global food demands, pharmaceuticals, and agricultural productivity. Applications in this area extend to genetic engineering, cloning, and the production of bio-pharmaceuticals. The end-use scope covers agriculture, pharmaceuticals, and research institutions seeking to enhance animal health and production efficiencies.

KEY MARKET STATISTICS
Base Year [2023] USD 28.64 billion
Estimated Year [2024] USD 31.04 billion
Forecast Year [2030] USD 50.59 billion
CAGR (%) 8.46%

Market growth is influenced by the rising global population, increasing food security concerns, and the shift towards sustainable agricultural processes. Biotechnology innovations such as genomics and gene-editing technologies like CRISPR/Cas9 drive advancements, contributing to crop and livestock robustness. However, potential opportunities lie in disease management in livestock, biopharmaceutical production, and improving animal welfare standards. Companies investing in research and development can leverage partnerships with academic and research institutions to foster innovation and expansive product lines. The market faces challenges like ethical debates, stringent regulatory frameworks, and limited consumer awareness, which may impede rapid adoption. Addressing these limitations requires transparent communication about benefits, risks, and ethical considerations, in conjunction with robust regulatory strategies to ensure acceptance and compliance.

The potential areas for innovation include next-generation sequencing, gene-editing advancements, and integrative bioinformatics for precision animal farming. Furthermore, focusing on global collaborations and cross-industry partnerships could bolster diversification and scalability. The nature of this market is dynamic, with a strong emphasis on sustainable practices and ethical considerations. Companies seeking growth must remain agile, fostering innovation and regulatory compliance to navigate the complex landscape of animal biotechnology. By addressing ethical and regulatory concerns and cultivating consumer trust, businesses can tap into the burgeoning demand for biotechnological advancements in animal agriculture and healthcare solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Animal Biotechnology Market

The Animal Biotechnology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising focus toward cloning and transgenic animals
    • Growing popularity and acceptance coupled with the regulatory approvals
    • Development of animal pharmaceuticals and preventive care for animals
  • Market Restraints
    • High cost ethical issues associated with the animal biotechnology products
  • Market Opportunities
    • Increasing animal meat consumption and the rising per capita animal healthcare expenditure
    • Production of transgenic livestock for agriculture
  • Market Challenges
    • Potential health effects to humans from food product

Porter's Five Forces: A Strategic Tool for Navigating the Animal Biotechnology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Animal Biotechnology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Animal Biotechnology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Animal Biotechnology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Animal Biotechnology Market

A detailed market share analysis in the Animal Biotechnology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Animal Biotechnology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Animal Biotechnology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Animal Biotechnology Market

A strategic analysis of the Animal Biotechnology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Animal Biotechnology Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, BioChek BV, Biogenesis Bago, Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, Heska Corporation, Hester Biosciences Limited, IDEXX Laboratories, Inc., Indian Immunologicals Ltd., Intervet Inc., Kareo, Inc., Merck & Co., Inc., Sanofi-Aventis Groupe S.A., Santa Cruz Biotechnology, Inc., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Biotechnology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Diagnostic Tests, Drugs, Reporductive & Genetic Produtcs, and Vaccines.
  • Based on Application, market is studied across Development of Animal Pharmaceuticals, Food Safety & Drug Development, and Preventive Care for Animals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising focus toward cloning and transgenic animals
      • 5.1.1.2. Growing popularity and acceptance coupled with the regulatory approvals
      • 5.1.1.3. Development of animal pharmaceuticals and preventive care for animals
    • 5.1.2. Restraints
      • 5.1.2.1. High cost ethical issues associated with the animal biotechnology products
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing animal meat consumption and the rising per capita animal healthcare expenditure
      • 5.1.3.2. Production of transgenic livestock for agriculture
    • 5.1.4. Challenges
      • 5.1.4.1. Potential health effects to humans from food product
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Animal Biotechnology Market, by Product

  • 6.1. Introduction
  • 6.2. Diagnostic Tests
  • 6.3. Drugs
  • 6.4. Reporductive & Genetic Produtcs
  • 6.5. Vaccines

7. Animal Biotechnology Market, by Application

  • 7.1. Introduction
  • 7.2. Development of Animal Pharmaceuticals
  • 7.3. Food Safety & Drug Development
  • 7.4. Preventive Care for Animals

8. Americas Animal Biotechnology Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Animal Biotechnology Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Animal Biotechnology Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bayer AG
  • 2. BioChek BV
  • 3. Biogenesis Bago
  • 4. Boehringer Ingelheim International GmbH
  • 5. Elanco Animal Health Incorporated
  • 6. Heska Corporation
  • 7. Hester Biosciences Limited
  • 8. IDEXX Laboratories, Inc.
  • 9. Indian Immunologicals Ltd.
  • 10. Intervet Inc.
  • 11. Kareo, Inc.
  • 12. Merck & Co., Inc.
  • 13. Sanofi-Aventis Groupe S.A.
  • 14. Santa Cruz Biotechnology, Inc.
  • 15. Virbac S.A.
  • 16. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. ANIMAL BIOTECHNOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. ANIMAL BIOTECHNOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ANIMAL BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ANIMAL BIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANIMAL BIOTECHNOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANIMAL BIOTECHNOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTIC TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REPORDUCTIVE & GENETIC PRODUTCS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DEVELOPMENT OF ANIMAL PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FOOD SAFETY & DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PREVENTIVE CARE FOR ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ANIMAL BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. ANIMAL BIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023